Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2018.12.29
招商资管-公司员工持股妄想简单资产治理条约
2018.12.29
2018年第五次暂时股东大会决议通告
2018.12.29
2018年第五次暂时股东大会的执法意见书
2018.12.27
关于控股股东部分股权扫除质押的通告
2018.12.25
北京市中伦(深圳)状师事务所关于公司第三期员工持股妄想的执法意见书
2018.12.12
关于使用部分超募资金永世性增补流动资金的通告
2018.12.12
第四届董事会第十九次聚会决议通告
2018.12.12
关于公司及全资孙公司向银行申请授信暨担保事项的通告
2018.12.12
第三期员工持股妄想(草案)
2018.12.12
中天堂富证券有限公司关于公司使用部分超募资金永世性增补流动资金的核查意见
第一页
上一页
47
48
49
50
51
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】